Schedule 13G ownership disclosure

MOLECULIN BIOTECH INC

Security class unavailable · CUSIP: 60855D101

Event date: 2019-04-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,125,000
Percent of class
7.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-026299
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
May 02, 2019
Reporting period
Apr 23, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub